Andy Batts
Long only, value, growth, momentum

Symmetry Medical: Grossly Undervalued Despite Debt Load

Symmetry Medical (NYSE:SMA) recently announced that its subsidiary Symmetry Surgical has launched Bookwalter Femoral Elevator for total hip arthroplasty ("THA") using direct anterior approach ("DAA"). Hospitals and surgery centers can now install the product through SMA's OEM solutions team.

In November last year, I recommend SMA in an article at $8 with a medium-term target of $11.46. In the last few weeks the stock has seen a mild correction from $10.75 to just below $9.50 and I believe that the correction offers a decent buying opportunity, particularly in light of its newest innovation in its industry-leading Bookwalter portfolio coupled with its turnaround initiatives. The stock didn't quite recover since the financial crisis of 2008 because of various internal...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details